Berbamine increases myocardial contractility via a Ca 2+- independent mechanism

Journal of Cardiovascular Pharmacology

Volumn 58, Issue 1, 2011, Pages 40-48

  Zhang, Cai Mei ^a   Gao, Ling ^a   Zheng, Yan Jun ^a   Yang, Huang Tian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Berberis vulgaris L; Ca 2+ transients; heart; positive inotropy; protein kinase Ce

Indexed keywords

BERBAMINE; CALCIUM ION; PROTEIN KINASE C EPSILON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BENZYLISOQUINOLINES; CALCIUM; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79960406153     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31821b70d1     Document Type: Article

References (51)

1. Endoh M. Changes in intracellular Ca2+ mobilization and Ca2+ sensitization as mechanisms of action of physiological interventions and inotropic agents in intact myocardial cells. Jpn Heart J. 1998;39:1-44. (Pubitemid 28105429)
2. Cohn JN, Goldstein SO, Greenberg BH, et al. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. N Engl J Med. 1998;339:1810-1816. (Pubitemid 29005785)
3. Perrone SV, Kaplinsky EJ. Calcium sensitizer agents: a new class of inotropic agents in the treatment of decompensated heart failure. Int J Cardiol. 2005;103:248-255. (Pubitemid 41132591)
4. Lee JA, Allen DG. Calcium sensitisers: mechanisms of action and potential usefulness as inotropes. Cardiovasc Res. 1997;36:10-20. (Pubitemid 27463567)
5. Meyer K, Klocke RC, Schipke JD, et al. Ca2+ sensitizer superior to catecholamine during myocardial stunning? Eur J Cardiothorac Surg. 2008;34:326-331.
6. Hajjar RJ, Schmidt U, Helm P, et al. Ca++ sensitizers impair cardiac relaxation in failing human myocardium. J Pharmacol Exp Ther. 1997; 280:247-254. (Pubitemid 27171409)
7. Davidson P, Hancock K, Leung D, et al. Traditional Chinese Medicine and heart disease: what does Western medicine and nursing science know about it? Eur J Cardiovasc Nurs. 2003;2:171-181. (Pubitemid 37153164)
8. Ren Y, Lu L, Guo TB, et al. Novel immunomodulatory properties of berbamine through selective down-regulation of STAT4 and action of IFN-gamma in experimental autoimmune encephalomyelitis. J Immunol. 2008;181:1491-1498.
9. Wang S, Liu Q, Zhang Y, et al. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action. Mol Cancer. 2009;8:81.
10. Li BY, Yang BF, Li WH. Effects of berbamine on hemodynamics and myocardial reperfusion injury in isolated working rabbit hearts. Zhongguo Yao Li Xue Bao. 1991;12:48-52.
11. Noland TA Jr, Kuo JF. Phosphorylation of cardiac myosin light chain 2 by protein kinase C and myosin light chain kinase increases Ca(2+)- stimulated actomyosin MgATPase activity. Biochem Biophys Res Commun. 1993;193:254-260. (Pubitemid 23199940)
12. Chan JY, Takeda M, Briggs LE, et al. Identification of cardiac-specific myosin light chain kinase. Circ Res. 2008;102:571-580. (Pubitemid 351416756)
13. Rajashree R, Blunt BC, Hofmann PA. Modulation of myosin phosphatase targeting subunit and protein phosphatase 1 in the heart. Am J Physiol Heart Circ Physiol. 2005;289:H1736-H1743. (Pubitemid 41369019)
14. Shaw EE, Wood P, Kulpa J, et al. Relaxin alters cardiac myofilament function through a PKC-dependent pathway. Am J Physiol Heart Circ Physiol. 2009;297:H29-H36.
15. Pi Y, Walker JW. Diacylglycerol and fatty acids synergistically increase cardiomyocyte contraction via activation of PKC. Am J Physiol Heart Circ Physiol. 2000;279:H26-H34. (Pubitemid 30616644)
16. Grimm M, Mahnecke N, Soja F, et al. The MLCK-mediated alpha1- adrenergic inotropic effect in atrial myocardium is negatively modulated by PKCepsilon signaling. Br J Pharmacol. 2006;148:991-1000. (Pubitemid 44543617)
17. Varma DR, Rindt H, Chemtob S, et al. Mechanism of the negative inotropic effects of alpha 1-adrenoceptor agonists on mouse myocardium. Can J Physiol Pharmacol 2003;81:783-789.
18. Chu L, Takahashi R, Norota I, et al. Signal transduction and Ca2+ signaling in contractile regulation induced by crosstalk between endothelin-1 and norepinephrine in dog ventricular myocardium. Circ Res. 2003;92: 1024-1032. (Pubitemid 36588502)
19. Li D, Yang C, Chen Y, et al. Identification of a PKCepsilon-dependent regulation of myocardial contraction by epicatechin-3-gallate. Am J Physiol Heart Circ Physiol. 2008;294:H345-H353.
20. Xie Y, Zhu Y, Zhu WZ, et al. Role of dual-site phospholamban phosphorylation in intermittent hypoxia-induced cardioprotection against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2005;288: H2594-H2602. (Pubitemid 40720635)
21. Yu Z, Wang ZH, Yang HT. Calcium/calmodulin-dependent protein kinase II mediates cardioprotection of intermittent hypoxia against ischemicreperfusion- induced cardiac dysfunction. Am J Physiol Heart Circ Physiol. 2009;297:H735-H742.
22. Hussain RI, Qvigstad E, Birkeland JA, et al. Activation of muscarinic receptors elicits inotropic responses in ventricular muscle from rats with heart failure through myosin light chain phosphorylation. Br J Pharmacol. 2009;156:575-586.
23. Andersen GO, Qvigstad E, Schiander I, et al. Alpha(1)-AR-induced positive inotropic response in heart is dependent on myosin light chain phosphorylation. Am J Physiol Heart Circ Physiol. 2002;283:H1471-H1480.
24. Hassouna A, Matata BM, Galinanes M. PKC-epsilon is upstream and PKC-alpha is downstream of mitoKATP channels in the signal transduction pathway of ischemic preconditioning of human myocardium. Am J Physiol Cell Physiol. 2004;287:C1418-C1425. (Pubitemid 39382903)
25. Johnson JA, Gray MO, Chen CH, et al. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem. 1996;271:24962-24966. (Pubitemid 26333253)
26. Gao H, Chen L, Yang HT. Activation of alpha1B-adrenoceptors alleviates ischemia/reperfusion injury by limitation of mitochondrial Ca2+ overload in cardiomyocytes. Cardiovasc Res. 2007;75:584-595. (Pubitemid 47086308)
27. Bassani JW, Bassani RA, Bers DM. Relaxation in rabbit and rat cardiac cells: species-dependent differences in cellular mechanisms. J Physiol. 1994;476:279-293. (Pubitemid 24129810)
28. Gable BD, Shiga T, Murray PA, et al. Propofol increases contractility during alpha1a-adrenoreceptor activation in adult rat cardiomyocytes. Anesthesiology. 2005;103:335-343. (Pubitemid 41076731)
29. Chen L, Lu XY, Li J, et al. Intermittent hypoxia protects cardiomyocytes against ischemia-reperfusion injury-induced alterations in Ca2+ homeostasis and contraction via the sarcoplasmic reticulum and Na+/Ca2+ exchange mechanisms. Am J Physiol Cell Physiol. 2006;290: C1221-C1229.
30. Inserte J, Barba I, Hernando V, et al. Effect of acidic reperfusion on prolongation of intracellular acidosis and myocardial salvage. Cardiovasc Res. 2008;77:782-790. (Pubitemid 351301862)
31. Huang XP, Pi Y, Lokuta AJ, et al. Arachidonic acid stimulates protein kinase C-epsilon redistribution in heart cells. J Cell Sci. 1997;110(pt 14): 1625-1634.
32. Lu XY, Chen L, Cai XL, et al. Overexpression of heat shock protein 27 protects against ischaemia/reperfusion-induced cardiac dysfunction via stabilization of troponin I and T. Cardiovasc Res. 2008;79:500-508.
33. Okamto R, Kato T, Mizoguchi A, et al. Characterization and function of MYPT2, a target subunit of myosin phosphatase in heart. Cell Signal. 2006;18:1408-1416. (Pubitemid 43832078)
34. Deng XF, Mulay S, Varma DR. Role of Ca(2+)-independent PKC in alpha 1-adrenoceptor-mediated inotropic responses of neonatal rat hearts. Am J Physiol. 1997;273(pt 2):H1113-H1118.
35. Kang M, Walker JW. Protein kinase C delta and epsilon mediate positive inotropy in adult ventricular myocytes. J Mol Cell Cardiol. 2005;38:753-764. (Pubitemid 40591740)
36. Hu ZY, Gong YS, Huang WL. Interaction of berbamine compound E6 and calmodulin-dependent myosin light chain kinase. Biochem Pharmacol. 1992;44:1543-1547.
37. Xu YH, Zhang SP. A derivative of bisbenzylisoquinoline alkaloid is a new and potential calmodulin antagonist. Biochem Biophys Res Commun. 1986;140:461-467.
38. Maier LS, Bers DM. Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc Res. 2007;73:631-640. (Pubitemid 46227343)
39. Vila-Petroff M, Perez GN, Alvarez B, et al. Mechanism of negative lusitropic effect of alpha 1-adrenoceptor stimulation in cat papillary muscles. Am J Physiol. 1996;270(pt 2):H701-H709.
40. Grossman W. Diastolic function and heart failure: an overview. Eur Heart J. 1990;11(suppl C):2-7. (Pubitemid 20179612)
41. Honerjager P, Nawrath H. Pharmacology of bipyridine phosphodiesterase III inhibitors. Eur J Anaesthesiol Suppl. 1992;5:7-14.
42. Reuter H, Henderson SA, Han T, et al. The Na+-Ca2+ exchanger is essential for the action of cardiac glycosides. Circ Res. 2002;90:305-308. (Pubitemid 34633932)
43. Teerlink JR, Metra M, Zaca V, et al. Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond. Heart Fail Rev. 2009;14:243-253.
44. Banfor PN, Preusser LC, Campbell TJ, et al. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs. Am J Physiol Heart Circ Physiol. 2008;294:H238-H248.
45. Schulz R, Rose J, Martin C, et al. Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and inotropic stimulation. Circulation. 1993;88:684-695. (Pubitemid 23228069)
46. Arteaga GM, Warren CM, Milutinovic S, et al. Specific enhancement of sarcomeric response to Ca2+ protects murine myocardium against ischemia-reperfusion dysfunction. Am J Physiol Heart Circ Physiol. 2005;289:H2183-H2192. (Pubitemid 41507372)
47. Than N, Shah N, White J, et al. Effects of acidosis and hypoxia on the response of isolated ferret cardiac muscle to inotropic agents. Cardiovasc Res. 1994;28:1209-1217. (Pubitemid 24264728)
48. Morano I. Tuning the human heart molecular motors by myosin light chains. J Mol Med. 1999;77:544-555. (Pubitemid 29426312)
49. Venema RC, Raynor RL, Noland TA Jr, et al. Role of protein kinase C in the phosphorylation of cardiac myosin light chain 2. Biochem J. 1993; 294(pt 2):401-406. (Pubitemid 23268838)
50. Meyer M, Lehnart S, Pieske B, et al. Influence of endothelin 1 on human atrial myocardium-myocardial function and subcellular pathways. Basic Res Cardiol. 1996;91:86-93.
51. Kang M, Walker JW. Endothelin-1 and PKC induce positive inotropy without affecting pHi in ventricular myocytes. Exp Biol Med (Maywood). 2006;231:865-870. (Pubitemid 43845543)